High cholesterol care in Bopal, Ahmedabad. Understand your lipid profile, LDL targets, lifestyle changes and medication options with Dr. Kulin Sheth.
Cholesterol cannot travel freely through blood. It is carried inside small particles called lipoproteins. LDL and HDL are different types of these particles. Triglycerides are another kind of fat carried in the bloodstream.
A lipid profile usually reports total cholesterol, LDL cholesterol, HDL cholesterol and triglycerides. Each tells us something different.
LDL carries cholesterol around the body. Some LDL particles can enter and become trapped in artery walls. Over time, this can trigger inflammation and plaque formation. Plaque may narrow an artery; if it breaks open, a clot can form and cause a heart attack or some types of stroke.
LDL is often called “bad cholesterol”, but the label is only shorthand. The concern is prolonged exposure to too many cholesterol-carrying particles. Both the level and the years of exposure matter. Lowering LDL with appropriate treatment reduces cardiovascular risk; it does not guarantee that an event can never occur.
HDL helps move cholesterol between tissues and the liver. It is often called “good cholesterol”, but the number on a report does not measure all the work HDL particles do.
Low HDL can be a clue to increased cardiovascular risk. However, prescribing medicines simply to raise HDL has not been shown to prevent heart attacks or strokes. Treatment therefore focuses on measures that improve outcomes, rather than chasing an HDL number. A high HDL result also does not cancel the risk from high LDL, tobacco use or diabetes.
Triglycerides store and transport energy. Raised levels may accompany diabetes, excess weight, alcohol intake, certain medicines or inherited conditions.
A modestly raised triglyceride result does not automatically mean you need a separate tablet. The first steps commonly include reviewing the cause, food and alcohol intake, blood-sugar control and overall cardiovascular risk. LDL and non-HDL management remain important.
There are exceptions. Severe triglyceride elevation needs prompt assessment because it can increase the risk of pancreatitis, a painful inflammation of the pancreas. Levels around 500 mg/dL or above warrant particular attention, with greater concern as levels rise further. Selected higher-risk patients with persistent triglyceride elevation may also benefit from a specific prescription treatment. Ordinary fish-oil supplements are not interchangeable with these medicines.
Non-HDL cholesterol is total cholesterol minus HDL cholesterol. It includes the cholesterol in LDL and other particles that can contribute to plaque. It is especially useful when triglycerides are raised. Indian guidance recognises its importance alongside LDL.
A laboratory’s reference range is not necessarily your treatment goal. Someone without known artery disease and someone who has already had a heart attack may need different targets even if their reports look similar.
For example, CSI guidance uses LDL goals below 70 mg/dL for high-risk patients and below 55 mg/dL for very-high-risk patients. These categories require clinical assessment; they are not universal cutoffs for everyone reading this page. Your starting LDL level, diagnosis, treatment response and tolerability also matter.
Depending on your history and results, assessment may include:
These tests answer different questions. They do not all need repeating at every visit.
For someone without known cardiovascular disease, treatment aims to reduce the chance of a first heart attack or stroke. Decisions consider age, cholesterol levels, blood pressure, tobacco exposure, diabetes, kidney health and family history.
After a heart attack, coronary stent, bypass operation or other established atherosclerotic disease, cholesterol treatment helps reduce the risk of further events. A result marked “normal” by the laboratory may still be above the appropriate treatment goal.
Markedly elevated LDL or a suspected inherited disorder needs particular attention. A young age or a reassuring short-term risk estimate should not be used on its own to dismiss lifelong exposure.
Persistently high LDL, especially alongside heart disease at a young age in close relatives, may suggest familial hypercholesterolaemia. This is an inherited condition, not evidence that someone has failed to eat properly. Assessment may lead to advice about testing close family members, including children through an appropriate clinician.
A lipid profile measures blood fats. It cannot show whether an artery is narrowed or how severe a blockage might be. Equally, a reassuring cholesterol result cannot rule out Coronary Artery Disease
Further testing depends on the clinical question. In selected people without symptoms, coronary calcium scoring can help clarify an uncertain prevention decision. It is not a routine test for every raised cholesterol result and does not replace assessment of chest pain.
The aim is an eating pattern you can sustain. A Gujarati or Indian diet can be adapted without replacing familiar meals with expensive “health foods”.
Being vegetarian does not automatically protect against an unhealthy lipid pattern. Preparation, portions and the overall balance of meals matter. Advice should also account for diabetes, kidney disease, weight, nutritional needs and food preferences.
Plan around occasions you actually celebrate. At a Diwali visit or wedding, choose what you most want to eat and a portion that fits your plan, rather than repeatedly grazing through sweets and fried snacks. For Navratri or other religious fasts, discuss suitable meals if you have diabetes or take regular medicines; a “farali” label does not by itself establish a food’s suitability.
Avoid compensating for a celebration by skipping prescribed treatment. Discuss medication timing before fasting if your routine will change.
Regular activity supports cardiovascular health even when weight changes slowly. Walking, cycling, swimming or other enjoyable activity can be built into the week, with gradual progression suited to your health and fitness. If you have symptoms or established heart disease, ask what level is appropriate.
If excess weight is contributing to [cardiometabolic risk](/conditions/obesity-cardiometabolic-health/), agree on achievable changes without making body weight the only measure of progress. Avoid smoking and smokeless tobacco.
Your prevention plan should also address [high blood pressure](/conditions/hypertension/) and the [cardiovascular risks associated with diabetes](/conditions/diabetes-and-heart-disease/) where relevant.
Lifestyle changes remain useful whether or not medication is prescribed. Some lower-risk patients can begin with a monitored lifestyle plan. Others, particularly those with established artery disease, markedly elevated LDL or inherited disorders, should not delay appropriate medication while waiting for diet alone to work.
Statins are commonly the first medicines used. They reduce cholesterol production in the liver and help the liver remove LDL from the blood. Their purpose is to reduce future cardiovascular events, not simply improve the appearance of a report.
If the agreed goal is not reached, or a statin is not tolerated, options may include ezetimibe, bempedoic acid or injectable treatments such as PCSK9 inhibitors. Choice depends on the clinical indication, expected benefit, tolerability, interactions and affordability. Different treatments do not all have identical evidence for preventing cardiovascular events.
If you are pregnant, breastfeeding or planning pregnancy, arrange a medication review. Cholesterol treatment requires a different assessment during these stages.
Report new muscle symptoms or other concerns. Symptoms during statin treatment are not automatically caused by the medicine, but they should be taken seriously. Assessment may include other causes, interacting medicines and whether a different dose, statin or combination is suitable.
Severe muscle pain or weakness, especially with dark urine, needs urgent medical assessment. Statins can also modestly increase the chance of diabetes in susceptible people; for patients with an appropriate indication, cardiovascular benefits generally outweigh this risk.
A lipid profile is commonly repeated about 4–12 weeks after starting or changing treatment, with earlier review where the clinical situation requires it. Once treatment is stable, testing is often spaced to 6–12 months, adjusted to your needs.
Follow-up considers the achieved LDL and non-HDL levels, whether medicines are being taken as agreed, side effects and changes in health. Liver or muscle tests are selected according to the medicine, history and symptoms; everyone does not need the same repeated safety-test panel.
A second opinion can help when you are uncertain about starting long-term medication, adding another treatment or managing suspected side effects.
Dr. Kulin Sheth personally reviews existing reports and relevant images before deciding whether additional assessment is needed. Bring previous lipid profiles, your current prescriptions and any records of heart disease. The discussion can clarify the reason for treatment, your goal and the available alternatives.
New chest pressure or discomfort, breathlessness, sweating, or pain spreading to the arm, jaw or back may need emergency assessment. Sudden facial drooping, arm weakness or speech difficulty may indicate a stroke. Seek emergency care immediately rather than waiting for a cholesterol appointment or second opinion.
If triglycerides are severely elevated and you develop severe, persistent upper abdominal pain, particularly with vomiting, seek urgent assessment.
For a cholesterol assessment or review of an existing treatment plan, book a consultation at Sheth Heart Clinic, Bopal, Ahmedabad. Bring your current medicines, previous lipid reports and relevant medical records.